SCHEMBL22033341

SCHEMBL22033341

O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(N2CCCS2(=O)=O)ccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX1 P51575 6/20 0.47
▸ P2RX4 Q99571 4/20 0.47
▸ P2RX7 Q99572 4/20 0.47
▸ TMPRSS4 Q9NRS4 3/20 0.47
▸ TP53 P04637 6/20 0.47
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ IKBKB O14920 1/20 0.46
▸ CHUK O15111 1/20 0.46
▸ KDR P35968 1/20 0.46
▸ FLT3 P36888 1/20 0.46
▸ MYLK Q15746 1/20 0.46
▸ MAP4K5 Q9Y4K4 1/20 0.46
▸ JAK2 O60674 1/20 0.45
▸ JAK1 P23458 1/20 0.45
▸ TYK2 P29597 1/20 0.45
▸ XPO1 O14980 1/20 0.44
▸ TLR7 Q9NYK1 1/20 0.42
▸ JUN P05412 1/20 0.42
▸ NFKB1 P19838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22033574 0.95 TP53 (0.45) P2RX1P2RX4P2RX7TMPRSS4TP53
SCHEMBL22033381 0.91 RXFP1 (0.52) P2RX1P2RX4P2RX7TMPRSS4TP53
SCHEMBL22033338 0.91 P2RX1 (0.48) P2RX1P2RX4P2RX7TMPRSS4MEN1
SCHEMBL22032910 0.88 P2RX1 (0.45) P2RX1P2RX4P2RX7TMPRSS4TP53
SCHEMBL22082621 0.87 TP53 (0.44) TP53MEN1KMT2AMALT1
SCHEMBL22033064 0.86 TP53 (0.54) P2RX1P2RX4P2RX7TP53MEN1
SCHEMBL22032966 0.86 KMT2A (0.51) TP53MEN1KMT2A
SCHEMBL22033572 0.86 MEN1 (0.45) P2RX1P2RX4P2RX7TMPRSS4MEN1
SCHEMBL22032865 0.84 TP53 (0.56) P2RX1TMPRSS4TP53MEN1KMT2A
SCHEMBL22032948 0.84 TP53 (0.54) TP53MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020117877-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE AQUINNAH PHARMACEUTICALS, INC. (US) 2020-06-11 — — WO disclosed
WO-2020117877-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE AQUINNAH PHARMACEUTICALS, INC. (US) 2020-06-11 — — WO disclosed
Send feedback